{"title":"骨髓瘤病的蛋白质分析。","authors":"P M Carter, L Slater, J Lee, D Perry, J R Hobbs","doi":"10.1136/jcp.s1-6.1.45","DOIUrl":null,"url":null,"abstract":"The criteria for the admission of patients to the Medical Research Council's (MRC) myeloma trials are the finding of abnormal plasma cells in bone marrow films or sections and in addition either of characteristic skeletal lesions demonstrated radio-logically or of characteristic protein changes in the serum or urine. Ninety per cent of the patients in the first myeloma trial satisfied all three criteria (Medical Research Council, 1971).","PeriodicalId":75995,"journal":{"name":"Journal of clinical pathology. Supplement (Association of Clinical Pathologists)","volume":"6 ","pages":"45-53"},"PeriodicalIF":0.0000,"publicationDate":"1975-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jcp.s1-6.1.45","citationCount":"1","resultStr":"{\"title\":\"Protein analyses in myelomatosis.\",\"authors\":\"P M Carter, L Slater, J Lee, D Perry, J R Hobbs\",\"doi\":\"10.1136/jcp.s1-6.1.45\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The criteria for the admission of patients to the Medical Research Council's (MRC) myeloma trials are the finding of abnormal plasma cells in bone marrow films or sections and in addition either of characteristic skeletal lesions demonstrated radio-logically or of characteristic protein changes in the serum or urine. Ninety per cent of the patients in the first myeloma trial satisfied all three criteria (Medical Research Council, 1971).\",\"PeriodicalId\":75995,\"journal\":{\"name\":\"Journal of clinical pathology. Supplement (Association of Clinical Pathologists)\",\"volume\":\"6 \",\"pages\":\"45-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1975-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1136/jcp.s1-6.1.45\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical pathology. Supplement (Association of Clinical Pathologists)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jcp.s1-6.1.45\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical pathology. Supplement (Association of Clinical Pathologists)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jcp.s1-6.1.45","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The criteria for the admission of patients to the Medical Research Council's (MRC) myeloma trials are the finding of abnormal plasma cells in bone marrow films or sections and in addition either of characteristic skeletal lesions demonstrated radio-logically or of characteristic protein changes in the serum or urine. Ninety per cent of the patients in the first myeloma trial satisfied all three criteria (Medical Research Council, 1971).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
